TickerFactsScreenerDevelopers

ADMA BIOLOGICS, INC. (ADMA) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2016: $1.61M2017: $29.16M2018: $42.19M2019: $39.50M2020: $61.29M2021: $79.77M2022: $118.81M2023: $169.27M2024: $206.90M2025: $217.41M$217.41M
2016Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$217.41M+5.1%
2024$206.90M+22.2%
2023$169.27M+42.5%
2022$118.81M+48.9%
2021$79.77M+30.1%
2020$61.29M+55.2%
2019$39.50M-6.4%
2018$42.19M+44.7%
2017$29.16M+1715.3%
2016$1.61M—